{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:45:13Z","timestamp":1760060713896,"version":"build-2065373602"},"reference-count":39,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23fk0310505h0002","25H00006"],"award-info":[{"award-number":["23fk0310505h0002","25H00006"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japan Society for the Promotion of Science","award":["23fk0310505h0002","25H00006"],"award-info":[{"award-number":["23fk0310505h0002","25H00006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Core fucose is one of the most important glycans in HBV infection. In this study, we investigated whether Pholiota squarrosa lectin (PhoSL), a lectin that specifically binds to core fucose, exerts an inhibitory effect in an HBV infection model of normal human hepatocytes. Similarly to previous studies using hepatocellular carcinoma cells (HepG2-C4), the coexistence of PhoSL during HBV infection inhibited HBe antigen production and HBV cccDNA in normal human hepatocytes in a PhoSL concentration-dependent manner. Furthermore, this effect of PhoSL was found to be able to suppress HBe antigen production in a treatment period-dependent manner, even when PhoSL was administered after HBV infection. Our previous research has revealed that the mechanism by which PhoSL inhibits HBV infection is through physical inhibition by binding to the HBV receptor and inhibition of HBV entry into cells by inhibiting the phosphorylation of EGFR, a co-receptor for NTCP. Furthermore, this study suggested that PhoSL may also inhibit HBV proliferation in cells through other mechanisms that require further investigation. PhoSL is a lectin, derived from edible Pholiota squarrosa (shaggy scalycap) mushrooms, that is resistant to acid and heat. In addition, it has a low molecular weight and can be chemically synthesized, so it is expected to be used clinically as a new carbohydrate therapy for HBV in the future.<\/jats:p>","DOI":"10.3390\/v17091242","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T16:27:33Z","timestamp":1757953653000},"page":"1242","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential for Core Fucose-Targeted Therapy Against HBV Infection of Human Normal Hepatocytes"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1996-7740","authenticated-orcid":false,"given":"Shinji","family":"Takamatsu","sequence":"first","affiliation":[{"name":"Department of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, The University of Osaka, 1-7 Yamada-oka, Suita 565-0871, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Virology, Graduate School of Medicine, The University of Osaka, 2-2 Yamada-oka, Suita 565-0871, Osaka, Japan"},{"name":"Department of Microbiology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sakon","sequence":"additional","affiliation":[{"name":"Department of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, The University of Osaka, 1-7 Yamada-oka, Suita 565-0871, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, The University of Osaka, 1-7 Yamada-oka, Suita 565-0871, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honoka","family":"Hishii","sequence":"additional","affiliation":[{"name":"Department of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, The University of Osaka, 1-7 Yamada-oka, Suita 565-0871, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1350-0480","authenticated-orcid":false,"given":"Jumpei","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, The University of Osaka, 1-7 Yamada-oka, Suita 565-0871, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5641-8105","authenticated-orcid":false,"given":"Keiji","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Virology, Graduate School of Medicine, The University of Osaka, 2-2 Yamada-oka, Suita 565-0871, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9430-2362","authenticated-orcid":false,"given":"Eiji","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, The University of Osaka, 1-7 Yamada-oka, Suita 565-0871, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J. Viral Hepat."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1046\/j.1440-1746.2000.02097.x","article-title":"Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma","volume":"15","author":"Chu","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-13-9151-4_1","article-title":"Hepatitis B Virus Infection: Overview","volume":"1179","author":"Li","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e0084","DOI":"10.1097\/HC9.0000000000000084","article-title":"What will it take to cure hepatitis B?","volume":"7","author":"Jeng","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/14656566.2023.2211259","article-title":"Developments in pharmacotherapeutic agents for hepatitis B-how close are we to a functional cure?","volume":"24","author":"Khan","year":"2023","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/jac\/dkr215","article-title":"Directly acting antivirals against hepatitis C virus","volume":"66","author":"Soriano","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Rosato, V., Nevola, R., Dallio, M., Di Micco, P., Spinetti, A., Zeneli, L., Ciancio, A., Milella, M., Colombatto, P., and D\u2019Adamo, G. (2024). Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration. J. Clin. Med., 13.","DOI":"10.3390\/jcm13195807"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhu, X., Jia, L., Yue, M., Zhang, A., Xia, X., Yu, R., Chen, H., and Huang, P. (2024). DAA treatment for HCV reduce risk of hepatocellular carcinoma: A 10-years follow-up study based on Chinese patients with hepatitis C. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-75280-w"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-0-12-394316-3.00004-1","article-title":"The SLC10 carrier family: Transport functions and molecular structure","volume":"70","author":"Geyer","year":"2012","journal-title":"Curr. Top. Membr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1128\/JVI.01855-15","article-title":"A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide","volume":"89","author":"Kaneko","year":"2015","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chen, Y., Duan, M., Wang, X., Xu, J., Tian, S., Xu, X., Duan, A., Mahal, A., Zhu, Y., and Zhu, Q. (2024). Synthesis and evaluation of pentacyclic triterpenoids conjugates as novel HBV entry inhibitors targeting NTCP receptor. Bioorg. Chem., 147.","DOI":"10.1016\/j.bioorg.2024.107385"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1099\/vir.0.81646-0","article-title":"Hepatitis C virus entry: Potential receptors and their biological functions","volume":"87","author":"Cocquerel","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1158\/1078-0432.CCR-1047-3","article-title":"Expression of N-acetylglucosaminyltransferase v is associated with prognosis and histology in non-small cell lung cancers","volume":"10","author":"Miyoshi","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"19747","DOI":"10.1074\/jbc.M311627200","article-title":"Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration","volume":"279","author":"Isaji","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1146\/annurev.bi.57.070188.004033","article-title":"Glycobiology","volume":"57","author":"Rademacher","year":"1988","journal-title":"Annu. Rev. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Mawatari, M., Saito, R., Hibino, A., Kondo, H., Yagami, R., Odagiri, T., Tanabe, I., Shobugawa, Y., and Group, J.I.C.S. (2019). Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224683"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15171\/bi.2018.16","article-title":"An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development","volume":"8","author":"Lotfi","year":"2018","journal-title":"Bioimpacts"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, Y., Liu, D., Wang, Y., Su, W., Liu, G., and Dong, W. (2021). The Importance of Glycans of Viral and Host Proteins in Enveloped Virus Infection. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.638573"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1248\/bpb.28.399","article-title":"Sialobiology of influenza: Molecular mechanism of host range variation of influenza viruses","volume":"28","author":"Suzuki","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Saso, W., Yamasaki, M., Nakakita, S.I., Fukushi, S., Tsuchimoto, K., Watanabe, N., Sriwilaijaroen, N., Kanie, O., Muramatsu, M., and Takahashi, Y. (2022). Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010590"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2017.03.007","article-title":"Antiviral lectins: Selective inhibitors of viral entry","volume":"142","author":"Mitchell","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1074\/jbc.M411122200","article-title":"Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp.","volume":"280","author":"Mori","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Jacob, I.B., Gemmiti, A., Xiong, W., Reynolds, E., Nicholas, B., Thangamani, S., Jia, H., and Wang, G. (2024). Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1370511"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-4165(99)00167-1","article-title":"Glycoprotein glycosylation and cancer progression","volume":"1473","author":"Dennis","year":"1999","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_29","first-page":"1180","article-title":"Core-fucosylation plays a pivotal role in hepatitis B pseudo virus infection: A possible implication for HBV glycotherapy","volume":"26","author":"Takamatsu","year":"2016","journal-title":"Glycobiology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"29721","DOI":"10.1074\/jbc.272.47.29721","article-title":"Evolution of fucosyltransferase genes in vertebrates","volume":"272","author":"Costache","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ouchida, T., Maeda, H., Akamatsu, Y., Maeda, M., Takamatsu, S., Kondo, J., Misaki, R., Kamada, Y., Ueda, M., and Ueda, K. (2023). The specific core fucose-binding lectin Pholiota squarrosa lectin (PhoSL) inhibits hepatitis B virus infection in vitro. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-28572-6"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"33973","DOI":"10.1074\/jbc.M111.327692","article-title":"A novel core fucose-specific lectin from the mushroom Pholiota squarrosa","volume":"287","author":"Kobayashi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1128\/JVI.02776-15","article-title":"Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx","volume":"90","author":"Kouwaki","year":"2016","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ueda, K., and Suwanmanee, Y. (2022). ATP5B Is an Essential Factor for Hepatitis B Virus Entry. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179570"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"31715","DOI":"10.1074\/jbc.M113.501122","article-title":"Interleukin-1 and tumor necrosis factor-\u03b1 trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID)","volume":"288","author":"Watashi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/cas.12799","article-title":"Novel reporter system to monitor early stages of the hepatitis B virus life cycle","volume":"106","author":"Nishitsuji","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1073\/pnas.84.2.444","article-title":"Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA","volume":"84","author":"Tsurimoto","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/(SICI)1097-0215(19980130)75:3<444::AID-IJC19>3.0.CO;2-8","article-title":"High expression of alpha-1-6 fucosyltransferase during rat hepatocarcinogenesis","volume":"75","author":"Noda","year":"1998","journal-title":"Int. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/hep.510280408","article-title":"Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: A possible implication for increased fucosylation of alpha-fetoprotein","volume":"28","author":"Noda","year":"1998","journal-title":"Hepatology"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/9\/1242\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:45:51Z","timestamp":1760035551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/9\/1242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["v17091242"],"URL":"https:\/\/doi.org\/10.3390\/v17091242","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}